Ligand id: 7347

Name: crisantaspase

No information available.
Summary of Clinical Use
Used to treat acute lymphoblastic leukemia (ALL) and some mast cells tumours [1]. The European Medicines Agency have delivered positive opinions on the use of several asparaginase formulations for the treatment of rare diseases.

For more information regarding current clinical trials testing crisantaspase, visit
Mechanism Of Action and Pharmacodynamic Effects
Some cancer cells are unable to synthesise the amino acid asparagine. Use of asparaginase effectively starves tumour cells of asparagine leading to cell death, whilst normal cells continue to produce their own asparagine and survive.
External links